Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study.

Autor: Saini, Sarbjit S1, Bindslev-Jensen, Carsten2, Maurer, Marcus3, Grob, Jean-Jacques4, Bülbül Baskan, Emel5, Bradley, Mary S6, Canvin, Janice7, Rahmaoui, Abdelkader6, Georgiou, Panayiotis7, Alpan, Oral8, Spector, Sheldon9, Rosén, Karin6
Zdroj: Journal of Investigative Dermatology. Jan2015, Vol. 135 Issue 1, p67-75. 9p.
Databáze: Academic Search Ultimate